|
GB8724885D0
(en)
|
1987-10-23 |
1987-11-25 |
Binns M M |
Fowlpox virus promotors
|
|
US5674722A
(en)
|
1987-12-11 |
1997-10-07 |
Somatix Therapy Corporation |
Genetic modification of endothelial cells
|
|
US5420032A
(en)
|
1991-12-23 |
1995-05-30 |
Universitge Laval |
Homing endonuclease which originates from chlamydomonas eugametos and recognizes and cleaves a 15, 17 or 19 degenerate double stranded nucleotide sequence
|
|
US5792632A
(en)
|
1992-05-05 |
1998-08-11 |
Institut Pasteur |
Nucleotide sequence encoding the enzyme I-SceI and the uses thereof
|
|
DE4228458A1
(de)
|
1992-08-27 |
1994-06-01 |
Beiersdorf Ag |
Multicistronische Expressionseinheiten und deren Verwendung
|
|
US6013516A
(en)
|
1995-10-06 |
2000-01-11 |
The Salk Institute For Biological Studies |
Vector and method of use for nucleic acid delivery to non-dividing cells
|
|
DE19539493A1
(de)
|
1995-10-24 |
1997-04-30 |
Thomae Gmbh Dr K |
Starker homologer Promotor aus Hamster
|
|
GB9526131D0
(en)
|
1995-12-21 |
1996-02-21 |
Celltech Therapeutics Ltd |
Recombinant chimeric receptors
|
|
WO1998011244A2
(en)
|
1996-09-11 |
1998-03-19 |
The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Aav4 vector and uses thereof
|
|
US7541034B1
(en)
|
1997-03-20 |
2009-06-02 |
The United States Of America As Represented By The Department Of Health And Human Services |
Recombinant antibodies and immunoconjugates targeted to CD-22 bearing cells and tumors
|
|
US6361996B1
(en)
|
1997-05-07 |
2002-03-26 |
University Of Utah Research Foundation |
Neuroepithelial stem cells and glial-restricted intermediate precursors
|
|
GB9710809D0
(en)
|
1997-05-23 |
1997-07-23 |
Medical Res Council |
Nucleic acid binding proteins
|
|
GB9710807D0
(en)
|
1997-05-23 |
1997-07-23 |
Medical Res Council |
Nucleic acid binding proteins
|
|
US6156303A
(en)
|
1997-06-11 |
2000-12-05 |
University Of Washington |
Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom
|
|
US5994136A
(en)
|
1997-12-12 |
1999-11-30 |
Cell Genesys, Inc. |
Method and means for producing high titer, safe, recombinant lentivirus vectors
|
|
US6140081A
(en)
|
1998-10-16 |
2000-10-31 |
The Scripps Research Institute |
Zinc finger binding domains for GNN
|
|
US8263402B1
(en)
|
1998-10-19 |
2012-09-11 |
Cornell Research Foundation, Inc. |
Method for isolating and purifying oligodendrocytes and oligodendrocyte progenitor cells
|
|
US6667176B1
(en)
|
2000-01-11 |
2003-12-23 |
Geron Corporation |
cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells
|
|
US6599692B1
(en)
|
1999-09-14 |
2003-07-29 |
Sangamo Bioscience, Inc. |
Functional genomics using zinc finger proteins
|
|
US6453242B1
(en)
|
1999-01-12 |
2002-09-17 |
Sangamo Biosciences, Inc. |
Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
|
|
US7070934B2
(en)
|
1999-01-12 |
2006-07-04 |
Sangamo Biosciences, Inc. |
Ligand-controlled regulation of endogenous gene expression
|
|
US6534261B1
(en)
|
1999-01-12 |
2003-03-18 |
Sangamo Biosciences, Inc. |
Regulation of endogenous gene expression in cells using zinc finger proteins
|
|
US7030215B2
(en)
|
1999-03-24 |
2006-04-18 |
Sangamo Biosciences, Inc. |
Position dependent recognition of GNN nucleotide triplets by zinc fingers
|
|
US6794136B1
(en)
|
2000-11-20 |
2004-09-21 |
Sangamo Biosciences, Inc. |
Iterative optimization in the design of binding proteins
|
|
AU776576B2
(en)
|
1999-12-06 |
2004-09-16 |
Sangamo Biosciences, Inc. |
Methods of using randomized libraries of zinc finger proteins for the identification of gene function
|
|
US6689558B2
(en)
|
2000-02-08 |
2004-02-10 |
Sangamo Biosciences, Inc. |
Cells for drug discovery
|
|
US8273570B2
(en)
|
2000-05-16 |
2012-09-25 |
Riken |
Process of inducing differentiation of embryonic cell to cell expressing neural surface marker using OP9 or PA6 cells
|
|
JP2002060786A
(ja)
|
2000-08-23 |
2002-02-26 |
Kao Corp |
硬質表面用殺菌防汚剤
|
|
US7575924B2
(en)
|
2000-11-13 |
2009-08-18 |
Research Development Foundation |
Methods and compositions relating to improved lentiviral vectors and their applications
|
|
US7067317B2
(en)
|
2000-12-07 |
2006-06-27 |
Sangamo Biosciences, Inc. |
Regulation of angiogenesis with zinc finger proteins
|
|
ATE437221T1
(de)
|
2001-05-14 |
2009-08-15 |
Gbp Ip Llc |
Lentivirale vektoren kodierend für gerinnungsfaktoren für die gentherapie
|
|
ATE527347T1
(de)
|
2001-08-02 |
2011-10-15 |
Inst Clayton De La Rech |
Verfahren und zusammensetzungen im zusammenhang mit verbesserten lentivirusvektor- produktionssystemen
|
|
JP2005500061A
(ja)
|
2001-08-20 |
2005-01-06 |
ザ スクリップス リサーチ インスティテュート |
Ｃｎｎについての亜鉛フィンガー結合ドメイン
|
|
US7355012B2
(en)
|
2001-09-26 |
2008-04-08 |
United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Mutated anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cells
|
|
RU2305708C2
(ru)
|
2001-10-02 |
2007-09-10 |
Энститю Клейтон Де Ля Решерш |
Рекомбинантный лентивирусный вектор, клетка-хозяин, трансдуцированная лентивирусным вектором, способ ее трансдукции и применение
|
|
MX359371B
(es)
|
2001-11-13 |
2018-09-25 |
Univ Pennsylvania |
Un metodo para detectar y/o identificar secuencias del virus adeno-asociado y aislamiento de secuencias novedosas identificadas de ese modo.
|
|
US7939059B2
(en)
|
2001-12-10 |
2011-05-10 |
California Institute Of Technology |
Method for the generation of antigen-specific lymphocytes
|
|
DK2573170T3
(en)
|
2001-12-17 |
2018-04-09 |
Univ Pennsylvania |
Sequences of adeno-associated virus (AAV) serotype 9, vectors containing them, and their use
|
|
US7262054B2
(en)
|
2002-01-22 |
2007-08-28 |
Sangamo Biosciences, Inc. |
Zinc finger proteins for DNA binding and gene regulation in plants
|
|
WO2003070171A2
(en)
|
2002-02-15 |
2003-08-28 |
Cornell Research Foundation, Inc. |
Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells
|
|
US20050101014A1
(en)
|
2002-07-11 |
2005-05-12 |
Keirstead Hans S. |
Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury
|
|
US7361635B2
(en)
|
2002-08-29 |
2008-04-22 |
Sangamo Biosciences, Inc. |
Simultaneous modulation of multiple genes
|
|
DE60333487D1
(de)
|
2002-12-13 |
2010-09-02 |
Genetix Pharmaceuticals Inc |
Therapeutische retrovirus-vektoren für gentherapie
|
|
BRPI0408733A
(pt)
|
2003-03-12 |
2006-03-07 |
Reliance Life Sciences Pvt Ltd |
derivação de neurÈnios dopaminérgicos terminalmente diferenciados de células tronco embriÈnicas humanas
|
|
US7888121B2
(en)
|
2003-08-08 |
2011-02-15 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
|
EP2345731B1
(en)
|
2003-09-30 |
2015-10-21 |
The Trustees of the University of Pennsylvania |
Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses thereof
|
|
US7982011B2
(en)
|
2003-11-25 |
2011-07-19 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Mutated anti-cd22 antibodies and immunoconjugates
|
|
US7972854B2
(en)
|
2004-02-05 |
2011-07-05 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
|
US7452718B2
(en)
|
2004-03-26 |
2008-11-18 |
Geron Corporation |
Direct differentiation method for making cardiomyocytes from human embryonic stem cells
|
|
US7253273B2
(en)
|
2004-04-08 |
2007-08-07 |
Sangamo Biosciences, Inc. |
Treatment of neuropathic pain with zinc finger proteins
|
|
AU2005232665B2
(en)
|
2004-04-08 |
2010-05-13 |
Sangamo Therapeutics, Inc. |
Methods and compositions for treating neuropathic and neurodegenerative conditions
|
|
ES2525067T3
(es)
|
2005-04-07 |
2014-12-17 |
The Trustees Of The University Of Pennsylvania |
Método de incremento de la función de un vector de AAV
|
|
JP5560393B2
(ja)
|
2005-06-22 |
2014-07-23 |
アステリアス バイオセラピューティクス インコーポレイテッド |
心筋細胞系列細胞への霊長類多能性幹細胞の分化
|
|
ES2582091T3
(es)
|
2005-10-18 |
2016-09-09 |
Precision Biosciences |
Meganucleasas diseñadas racionalmente con especificidad de secuencia y afinidad de unión a ADN alteradas
|
|
EP2132322A4
(en)
|
2007-03-02 |
2013-02-20 |
Richmond Chemical Corp |
METHOD FOR INCREASING YIELD AND IMPROVING PURIFICATION OF PRODUCTS FROM REACTIONS WITH TRANSAMINASE
|
|
DK2185192T3
(en)
|
2007-08-03 |
2019-02-18 |
Pasteur Institut |
LENTIVIRAL TRANSFER VECTORS AND THEIR MEDICAL USES
|
|
EP2028268A1
(en)
|
2007-08-20 |
2009-02-25 |
Université Libre De Bruxelles |
Generation of neuronal cells from pluripotent stem cells
|
|
WO2009057111A2
(en)
|
2007-10-29 |
2009-05-07 |
Hadasit Medical Research Services & Development Limited |
Human stem cell-derived neural precursors for treatment of autoimmune diseases of the central nervous system
|
|
US8227247B2
(en)
|
2007-12-20 |
2012-07-24 |
Wisconsin Alumni Research Foundation |
Method of generating myelinating oligodendrocytes
|
|
US8728812B2
(en)
|
2008-04-22 |
2014-05-20 |
President And Fellows Of Harvard College |
Compositions and methods for promoting the generation of PDX1+ pancreatic cells
|
|
KR20110011658A
(ko)
|
2008-05-08 |
2011-02-08 |
유니버시티 오브 로체스터 |
최적화된 세포 제제에 의한 수초 질환의 치료
|
|
US8669048B2
(en)
|
2008-06-24 |
2014-03-11 |
Parkinson's Institute |
Pluripotent cell lines and methods of use thereof
|
|
WO2010022395A2
(en)
|
2008-08-22 |
2010-02-25 |
President And Fellows Of Harvard College |
Methods of reprogramming cells
|
|
EP3187581A1
(en)
|
2008-12-23 |
2017-07-05 |
BOCO Silicon Valley, Inc. |
Target populations of oligodendrocyte precursor cells and methods of making and using same
|
|
US8507274B2
(en)
|
2009-02-06 |
2013-08-13 |
President And Fellows Of Harvard College |
Compositions and methods for promoting the generation of definitive endoderm
|
|
WO2010144696A1
(en)
|
2009-06-11 |
2010-12-16 |
Burnham Institute For Medical Research |
Directed differentiation of stem cells
|
|
US8586526B2
(en)
|
2010-05-17 |
2013-11-19 |
Sangamo Biosciences, Inc. |
DNA-binding proteins and uses thereof
|
|
WO2011091048A1
(en)
|
2010-01-19 |
2011-07-28 |
The Board Of Trustees Of The Leland Stanford Junior University |
Direct conversion of cells to cells of other lineages
|
|
WO2011130675A2
(en)
|
2010-04-16 |
2011-10-20 |
The Mclean Hospital Corporation |
Dopaminergic neurons differentiated from pluripotent stem cells and uses of thereof
|
|
US9089520B2
(en)
|
2010-05-21 |
2015-07-28 |
Baylor College Of Medicine |
Methods for inducing selective apoptosis
|
|
WO2011159726A2
(en)
|
2010-06-14 |
2011-12-22 |
The Scripps Research Institute |
Reprogramming of cells to a new fate
|
|
SG189269A1
(en)
|
2010-10-26 |
2013-05-31 |
Univ Case Western Reserve |
Differentiation methods for production of glial cell populations
|
|
PH12013501201A1
(en)
|
2010-12-09 |
2013-07-29 |
Univ Pennsylvania |
Use of chimeric antigen receptor-modified t cells to treat cancer
|
|
WO2012135253A1
(en)
|
2011-03-29 |
2012-10-04 |
Geron Corporation |
Enriched populations of cardiomyocyte lineage cells from pluripotent stem cells
|
|
DK2694644T3
(en)
|
2011-03-30 |
2018-04-16 |
Cellular Dynamics Int Inc |
Priming of pluripotent stem cells for neural differentiation
|
|
CA3111953C
(en)
|
2011-04-05 |
2023-10-24 |
Cellectis |
Method for the generation of compact tale-nucleases and uses thereof
|
|
CN111500665A
(zh)
|
2011-07-21 |
2020-08-07 |
小利兰·斯坦福大学托管委员会 |
来自患者的诱导性多能干细胞的心肌细胞及其使用方法
|
|
CN103946952A
(zh)
|
2011-09-16 |
2014-07-23 |
宾夕法尼亚大学董事会 |
用于治疗癌症的rna改造的t细胞
|
|
US8951798B2
(en)
|
2011-10-13 |
2015-02-10 |
Wisconsin Alumni Research Foundation |
Generation of cardiomyocytes from human pluripotent stem cells
|
|
US20140359799A1
(en)
|
2011-12-23 |
2014-12-04 |
Case Western Reserve University |
Targeted gene modification using hybrid recombinant adeno-associated virus
|
|
US9850463B2
(en)
|
2012-02-01 |
2017-12-26 |
The Regents Of The University Of California |
Methods of culturing retinal pigmented epithelium cells, including xeno-free production, RPE enrichment, and cryopreservation
|
|
WO2013130824A1
(en)
|
2012-02-29 |
2013-09-06 |
Sangamo Biosciences, Inc. |
Methods and compositions for treating huntington's disease
|
|
RU2766608C2
(ru)
|
2012-04-11 |
2022-03-15 |
Дзе Юнайтед Стейтс Оф Америка, Эз Репрезентед Бай Дзе Секретари, Департмент Оф Хелс Энд Хьюман Сёрвисез |
Химерные антигенные рецепторы, нацеленные на антиген созревания b-клеток
|
|
US9458428B2
(en)
|
2012-06-05 |
2016-10-04 |
The Regents Of The University Of California |
Methods and compositions for the rapid production of retinal pigmented epithelial cells from pluripotent cells
|
|
GB201212902D0
(en)
|
2012-07-20 |
2012-09-05 |
Univ Singapore |
Combinatoric encoding methods for microarrays
|
|
WO2014068079A1
(en)
|
2012-11-01 |
2014-05-08 |
Max-Delbrück-Centrum für Molekulare Medizin |
An antibody that binds cd269 (bcma) suitable for use in the treatment of plasma cell diseases such as multiple myeloma and autoimmune diseases
|
|
JP6541577B2
(ja)
|
2013-02-06 |
2019-07-10 |
ユニバーシティー オブ ロチェスター |
ミエリン障害の治療のための誘導多能性細胞由来オリゴデンドロサイト前駆細胞
|
|
EP3498824A1
(en)
|
2013-04-26 |
2019-06-19 |
Memorial Sloan-Kettering Cancer Center |
Cortical interneurons and other neuronal cells produced by the directed differentiation of pluripotent and multipotent cells
|
|
CA2939411A1
(en)
|
2014-02-27 |
2015-09-03 |
Ucl Business Plc |
Ligand
|
|
KR102526945B1
(ko)
|
2014-04-30 |
2023-04-27 |
막스-델부뤽-센트럼 퓌어 몰레쿨라레 메디친 인 데어 헬름홀츠-게마인샤프트 |
Ｃｄ269에 대한 인간화 항체
|
|
PL3145517T3
(pl)
|
2014-05-22 |
2021-04-06 |
New York Stem Cell Foundation, Inc. |
Funkcjonalne oligodendrocyty pochodzące z pluripotencjalnych komórek macierzystych oraz sposoby ich otrzymywania i stosowania
|
|
JP6651218B2
(ja)
|
2014-05-30 |
2020-02-19 |
国立大学法人京都大学 |
低分子化合物を用いた多能性幹細胞の心筋分化誘導法
|
|
BR112017001183A2
(pt)
|
2014-07-21 |
2017-11-28 |
Novartis Ag |
tratamento de câncer usando receptor de antígeno quimérico anti-bcma humanizado
|
|
ES2878449T3
(es)
|
2014-07-24 |
2021-11-18 |
2Seventy Bio Inc |
Receptores antigénicos quiméricos de BCMA
|
|
EP2990416B1
(en)
|
2014-08-29 |
2018-06-20 |
GEMoaB Monoclonals GmbH |
Universal chimeric antigen receptor expressing immune cells for targeting of diverse multiple antigens and method of manufacturing the same and use of the same for treatment of cancer, infections and autoimmune disorders
|
|
US9765299B2
(en)
|
2014-09-10 |
2017-09-19 |
Wisconsin Alumni Research Foundation |
Chemically defined albumin-free conditions for cardiomyocyte differentiation of human pluripotent stem cells
|
|
WO2016126608A1
(en)
|
2015-02-02 |
2016-08-11 |
Novartis Ag |
Car-expressing cells against multiple tumor antigens and uses thereof
|
|
AU2016243583B2
(en)
|
2015-03-27 |
2022-03-10 |
President And Fellows Of Harvard College |
Modified T cells and methods of making and using the same
|
|
US9724432B2
(en)
|
2015-04-30 |
2017-08-08 |
University Of Rochester |
Non-human mammal model of human degenerative disorder, uses thereof, and method of treating human degenerative disorder
|
|
CN107921148A
(zh)
|
2015-05-08 |
2018-04-17 |
哈佛学院校长同事会 |
通用供体干细胞和相关方法
|
|
HK1256610A1
(zh)
|
2015-08-15 |
2019-09-27 |
阿斯特利亚斯生物治疗股份公司 |
用於治疗白质中风的干细胞衍生的少突胶质细胞祖细胞
|
|
JP2018534264A
(ja)
|
2015-09-28 |
2018-11-22 |
リージェンツ オブ ザ ユニバーシティ オブ ミネソタ |
自己免疫および同種免疫への治療的介入としてのキメラ抗原受容体（ｃａｒ）ｔ細胞
|
|
US20180291080A1
(en)
|
2015-09-28 |
2018-10-11 |
Trustees Of Dartmouth College |
Chimeric antigen receptor, regulatory cells and methods of use
|
|
JP7235507B2
(ja)
|
2016-03-03 |
2023-03-08 |
ニューヨーク ステム セル ファウンデーション インコーポレイテッド |
多能性幹細胞由来のミクログリアならびにその作製および使用方法
|
|
WO2017172976A1
(en)
|
2016-03-29 |
2017-10-05 |
The Regents Of The University Of California |
Methods for promoting oligodendrocyte regeneration and remyelination
|
|
CA3025667A1
(en)
|
2016-06-08 |
2017-12-14 |
Intrexon Corporation |
Cd33 specific chimeric antigen receptors
|
|
KR101988912B1
(ko)
|
2016-07-08 |
2019-06-13 |
서울대학교산학협력단 |
패턴을 이용한 조골세포 분화 촉진용 배양지지체
|
|
WO2018093681A1
(en)
|
2016-11-15 |
2018-05-24 |
Neuralstem, Inc. |
Multipotent neural stem cells that express platelet derived growth factor (pdgf) receptor and methods of use thereof
|
|
JP2020505025A
(ja)
|
2017-01-13 |
2020-02-20 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
免疫工学的な改変をした多能性細胞
|
|
CN110650975B
(zh)
|
2017-05-15 |
2024-04-05 |
美国卫生和人力服务部 |
双顺反子嵌合抗原受体及其用途
|
|
WO2019005886A1
(en)
|
2017-06-26 |
2019-01-03 |
The Broad Institute, Inc. |
CRISPR / CAS-CYTIDINE DEAMINASE COMPOSITIONS, SYSTEMS AND METHODS FOR TARGETED EDITING OF NUCLEIC ACIDS
|
|
KR102761791B1
(ko)
|
2017-06-26 |
2025-02-05 |
더 브로드 인스티튜트, 인코퍼레이티드 |
표적화된 핵산 편집을 위한 crispr/cas-아데닌 데아미나아제 기반 조성물, 시스템 및 방법
|
|
US20210177953A1
(en)
*
|
2017-11-14 |
2021-06-17 |
Asclepius Therapy Llc |
Engineered Non-Human Derived Immune Cells for Universal Adoptive Antigen Cellular Immunotherapy
|
|
EP3728576A4
(en)
|
2017-12-22 |
2021-11-24 |
The Broad Institute, Inc. |
CAS12B SYSTEMS, METHODS AND COMPOSITIONS FOR SPECIFIC EDITING OF RNA BASES
|
|
US20210079366A1
(en)
|
2017-12-22 |
2021-03-18 |
The Broad Institute, Inc. |
Cas12a systems, methods, and compositions for targeted rna base editing
|
|
WO2019126709A1
(en)
|
2017-12-22 |
2019-06-27 |
The Broad Institute, Inc. |
Cas12b systems, methods, and compositions for targeted dna base editing
|
|
JP7646182B2
(ja)
|
2018-05-16 |
2025-03-17 |
ワシントン・ユニバーシティ |
内胚葉系統の細胞およびベータ細胞を生成するための方法および組成物、ならびにそれらの使用
|
|
WO2020018620A1
(en)
|
2018-07-17 |
2020-01-23 |
The Regents Of The University Of California |
Chimeric antigen receptor t cells derived from immunoengineered pluripotent stem cells
|
|
CA3109078A1
(en)
|
2018-07-17 |
2020-01-23 |
The Regents Of The University Of California |
Cells differentiated from immunoengineered pluripotent cells
|
|
WO2020051562A2
(en)
|
2018-09-07 |
2020-03-12 |
Beam Therapeutics Inc. |
Compositions and methods for improving base editing
|
|
WO2020181202A1
(en)
|
2019-03-06 |
2020-09-10 |
The Broad Institute, Inc. |
A:t to t:a base editing through adenine deamination and oxidation
|
|
WO2020181178A1
(en)
|
2019-03-06 |
2020-09-10 |
The Broad Institute, Inc. |
T:a to a:t base editing through thymine alkylation
|
|
WO2020181193A1
(en)
|
2019-03-06 |
2020-09-10 |
The Broad Institute, Inc. |
T:a to a:t base editing through adenosine methylation
|
|
WO2020181195A1
(en)
|
2019-03-06 |
2020-09-10 |
The Broad Institute, Inc. |
T:a to a:t base editing through adenine excision
|
|
WO2020191233A1
(en)
|
2019-03-19 |
2020-09-24 |
The Broad Institute, Inc. |
Methods and compositions for editing nucleotide sequences
|
|
US12473543B2
(en)
|
2019-04-17 |
2025-11-18 |
The Broad Institute, Inc. |
Adenine base editors with reduced off-target effects
|
|
WO2020228039A1
(en)
*
|
2019-05-16 |
2020-11-19 |
Egenesis, Inc. |
Cells, tissues, organs, and/or animals having one or more modified genes for enhanced xenograft survival and/or tolerance
|
|
EP3760718A1
(en)
*
|
2019-07-04 |
2021-01-06 |
Medizinische Hochschule Hannover |
Tissue for use as allogeneic or xenogeneic transplant and method for its production
|
|
US20220267732A1
(en)
*
|
2019-08-01 |
2022-08-25 |
Sana Biotechnology, Inc. |
Dux4 expressing cells and uses thereof
|
|
JP7728747B2
(ja)
*
|
2019-08-23 |
2025-08-25 |
サナ バイオテクノロジー，インコーポレイテッド |
Ｃｄ２４発現細胞およびそれらの用途
|
|
WO2021146222A1
(en)
|
2020-01-13 |
2021-07-22 |
Sana Biotechnology, Inc. |
Modification of blood type antigens
|
|
EP4100519A2
(en)
|
2020-02-05 |
2022-12-14 |
The Broad Institute, Inc. |
Adenine base editors and uses thereof
|
|
IL297761A
(en)
|
2020-05-08 |
2022-12-01 |
Broad Inst Inc |
Methods and compositions for simultaneously editing two helices of a designated double-helix nucleotide sequence
|
|
WO2022036150A1
(en)
*
|
2020-08-13 |
2022-02-17 |
Sana Biotechnology, Inc. |
Methods of treating sensitized patients with hypoimmunogenic cells, and associated methods and compositions
|
|
CA3193099A1
(en)
|
2020-09-24 |
2022-03-31 |
David R. Liu |
Prime editing guide rnas, compositions thereof, and methods of using the same
|